期刊文献+

泼尼松联合霉酚酸酯对比环磷酰胺治疗狼疮性肾炎的系统评价 被引量:40

Mycophenolate mofetil versus cyclophosphamide combined with prednisone in induction therapy for lupus nephritis: a systematic review
下载PDF
导出
摘要 目的系统评价泼尼松联合霉酚酸酯与环磷酰胺治疗狼疮性肾炎的疗效及安全性。方法检索Pub Med、MEDLINE、Embase、Cochrance图书馆临床对照试验资料库、中国期刊全文数据库(CNKI)、中文科技期刊全文数据库(维普)和万方数字化期刊全文库等,检索泼尼松联合霉酚酸酯(MMF)与环磷酰胺(CTX)治疗狼疮性肾炎的随机对照临床试验(检索时间均从建库至2013年12月),对完全缓解率、部分缓解率、总缓解率、感染、白细胞减少、胃肠道反应进行Meta分析。结果共纳入22篇文献(共1 641例),Meta分析结果显示,与泼尼松+CTX组比较,泼尼松+MMF组的完全缓解率及总缓解率高(P<0.01),而感染率、白细胞减少发生率低(P<0.01),两组间部分缓解率及胃肠道反应比较差异无统计学意义(P>0.05)。结论泼尼松联合MMF治疗狼疮性肾炎的缓解率较泼尼松联合CTX高,感染及白细胞减少的风险较小。 Objective To assess the efficacy and safety of mycophenolate mofetil( MMF) versus cyclophosphamide( CTX) combined with prednisone in the induction treatment for lupus nephritis( LN). Methods The database such as PubM ed,M EDLINE,Embase,the Cochrane Controlled Trials Register,CNKI,VIP and Wanfang were searched from their establishment date to December 2013,in order to retrieve the randomized controlled trials( RCTs)about MMF versus CTX combined with prednisone for LN. Meta-analysis was made to assess the complete remission,partial remission,total remission,infection,leucopenia,gastrointestinal symptoms. Results 22 studies involving 1641 participants were included. Meta-analysis showed: compared with CTX + predsione,M MF + predsione was more effective in complete remission and total remission( P 〈 0. 01),and the incidence of infection and leucopenia was lower( P 〈 0. 01),while there was no significant difference in partial remission and gastrointestinal symptoms between the two groups( P 〉 0. 05). Conclusion Prednisone + MM F treatment has higher renal remission rate than that of prednisone + CTX for LN patients,with lower risks of leukopenia and infection.
出处 《实用药物与临床》 CAS 2015年第2期130-135,共6页 Practical Pharmacy and Clinical Remedies
基金 "十二五"国家科技支撑计划课题(2013BAI06B04)
关键词 泼尼松 环磷酰胺 霉酚酸酯 狼疮性肾炎 META分析 Prednisone Cyclophosphamide Mycophenolate mofetil Lupus nephritis Meta-analysis
  • 相关文献

参考文献33

  • 1Mak A,Mok CC,Chu WP,et al.Renal damage in Systemic lupus erythematosus:a comparative analysis of different age groups[J].Lupus,2007,16(1):28-34. 被引量:1
  • 2Donadio JV Jr,Holley KE,Ferguson RH,et al.Treatment of diffuse proliferative lupus nephritis with prednisone and combined prednisone and cyclophosphamide[J].N Engl J M ed,1978,299:1151-1155. 被引量:1
  • 3Waldman M,Appel GB.Update on the treatment of lupus nephritis[J].Kidney Int,2006,70(8):1403-1412. 被引量:1
  • 4Martin F,Lauwerys B,Lefèbvre C,et al.Side-effects of intravenous cyclophosphamide pulse therapy[J].Lupus,1997,6(3):254-257. 被引量:1
  • 5Onishi A,Sugiyama D,Tsuji A,et al.Mycophenolate mofetil versus intravenous cyclophosphamide for induction treatment of proliferative lupus nephritis in a Japanese population:a retrospective study[J].M od Rheumatol,2013,23(1):89-96. 被引量:1
  • 6Appel GB,Contreras G,Dooley MA,et al.Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritisp[J].J Am Soc Nephrol,2009,20(5):1103-1112. 被引量:1
  • 7Chan TM,Li FK,Tang CS.Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis.Hong Kong-Guangzhou nephrology study group[J].N Engl J M ed,2000,343(16):1156-1162. 被引量:1
  • 8Chan TM,Tse KC,Tang CS,et al.Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis[J].J Am Soc Nephrol,2005,16(4):1076-1084. 被引量:1
  • 9Contreras G,Pardo V,Leclercq B.Sequential therapies for proliferative lupus nephritis[J].N Engl J M ed,2004,350(10):971-980. 被引量:1
  • 10El-shafey EM,Abdou SH.Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in egyptian patients[J].Clin Exp nephrol,2010,14(3):214-221. 被引量:1

二级参考文献115

共引文献75

同被引文献248

引证文献40

二级引证文献196

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部